Grupo Jaba

Jaba Recordati is a leading Portuguese pharmaceutical company and a key subsidiary of the international Recordati Group. Founded in 1927 as Grupo Jaba, the company has a long-standing presence in the Iberian healthcare market and Portuguese-speaking African countries (PALOP). The company specializes in the commercialization, distribution, and manufacturing of pharmaceutical products across several therapeutic areas, including cardiovascular health, urology, and the central nervous system. Following its acquisition by Recordati in 2006, Jaba Recordati has integrated global research and development resources to bolster its local portfolio of proprietary and licensed medicines. The company operates a significant manufacturing and logistics facility in Sintra, Portugal, serving both domestic and international markets.